These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 33057392)

  • 1. Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France.
    Mattern J; Vauloup-Fellous C; Zakaria H; Benachi A; Carrara J; Letourneau A; Bourgeois-Nicolaos N; De Luca D; Doucet-Populaire F; Vivanti AJ
    PLoS One; 2020; 15(10):e0240782. PubMed ID: 33057392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey.
    Tanacan A; Erol SA; Turgay B; Anuk AT; Secen EI; Yegin GF; Ozyer S; Kirca F; Dinc B; Unlu S; Yapar Eyi EG; Keskin HL; Sahin D; Surel AA; Tekin OM
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():31-34. PubMed ID: 32763728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seroprevalence among parturient women in Philadelphia.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Gerber JS; Arevalo CP; Bolton MJ; Weirick ME; Goodwin EC; Anderson EM; Greenplate AR; Kim J; Han N; Pattekar A; Dougherty J; Kuthuru O; Mathew D; Baxter AE; Vella LA; Weaver J; Verma A; Leite R; Morris JS; Rader DJ; Elovitz MA; Wherry EJ; Puopolo KM; Hensley SE
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32727884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
    Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
    Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-COV-2 IgG antibody response in pregnant women at delivery.
    Tsatsaris V; Mariaggi AA; Launay O; Couffignal C; Rousseau J; Ancel PY; Marcault E; Ville Y; Cordier AG; Vivanti A; Carrara J; Luton D; Dommergues M; Borie C; Kayem G; Alessandrini V; Lecomte L; Meritet JF; Leruez-Ville M; Goffinet F; Dubois C; Picone O; Vauloup Fellous C
    J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102041. PubMed ID: 33310133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal screening for SARS-CoV-2 in pregnant women at term admitted to an East London maternity unit.
    Abeysuriya S; Wasif S; Counihan C; Shah N; Iliodromiti S; Cutino-Moguel MT; Saeed F; Velauthar L
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():444-446. PubMed ID: 32731057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19.
    Gray N; Calleja D; Wimbush A; Miralles-Dolz E; Gray A; De Angelis M; Derrer-Merk E; Oparaji BU; Stepanov V; Clearkin L; Ferson S
    PLoS One; 2020; 15(10):e0240775. PubMed ID: 33085693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
    Sapkal G; Shete-Aich A; Jain R; Yadav PD; Sarkale P; Lakra R; Baradkar S; Deshpande GR; Mali D; Tilekar BN; Majumdar T; Kaushal H; Gurav Y; Gupta N; Mohandas S; Deshpande K; Kaduskar O; Salve M; Patil S; Gaikwad S; Sugunan AP; Ashok M; Giri S; Shastri J; Abraham P; Gangakhedkar RR;
    Indian J Med Res; 2020 May; 151(5):444-449. PubMed ID: 32611915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study.
    Prabhu M; Cagino K; Matthews KC; Friedlander RL; Glynn SM; Kubiak JM; Yang YJ; Zhao Z; Baergen RN; DiPace JI; Razavi AS; Skupski DW; Snyder JR; Singh HK; Kalish RB; Oxford CM; Riley LE
    BJOG; 2020 Nov; 127(12):1548-1556. PubMed ID: 32633022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
    Bryan A; Pepper G; Wener MH; Fink SL; Morishima C; Chaudhary A; Jerome KR; Mathias PC; Greninger AL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of lateral flow tests in SARS-CoV-2 infection monitorization.
    Candel FJ; Viñuela-Prieto JM; González Del Castillo J; Barreiro García P; Fragiel Saavedra M; Hernández Píriz A; Jiménez Virumbrales D; Canora Lebrato J; García de Casasola G; Gil Prieto R; San-Román Montero J; Ortega Anselmi J; Barba Martín R; Prados Roa F; Marco Martínez J; Zapatero Gaviria A
    Rev Esp Quimioter; 2020 Aug; 33(4):258-266. PubMed ID: 32492991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
    Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
    Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.